Bard® Inferior Vena Cava Filters
A Resource Center for Information on BARD IVC Filters
Clinical Studies

Everest

Presented by: John Kaufman, MD at the 2008 Society of Interventional Radiology
Annual Meeting, Washingtom DC, March 2008

Results of a Prospective, multi-center, non-consecutive single arm clinical trial.

  • Prospective, multi-center, non-randomized
  • 100 Patients
  • 140 Days Mean Indwell Time
  • 61 Filter Retrieval Attempts
  • 95% Retrieval Success Rate

Download Everest abstract

CHUM

Oliva, Vincent et al. “Recovery G2 Inferior Vena Cava Filter: Technical Success and Safety of Retrieval.” Journal of Vascular and Interventional Radiology; 2008;19:884-889

Purpose: To assess the safety and technical success of the retrieval of the Recovery® G2 filter when implanted for temporary protection against pulmonary embolism. Results of a Prospective, single-center, consecutive single arm clinical trial.

  • Prospective, single-center, non-randomized
  • 120 Patients
  • 53.4 Days Mean Indwell Time
  • 51 Filter Retrieval Attempts
  • 100% Retrieval Success Rate

G2 Inferior Vena Cava Filter: Retrievability and Safety

Charles, Hearns et al. Journal of Vascular and Interventional Radiology; 2009;TBD

Purpose: To assess the retrievability of the G2 inferior vena cava (IVC) filter and factors influencing the safety and technical success of retrieval.

  • Prospective, single-center, non-randomized
  • Mean Indwell Time 122 Days (range, 11-260 days)
  • 27 Filter Retrieval Attempts
  • 100% Technical Success
  • Tilting (>15°) occurred in 5 Patients (18.5%)
  • No Significant Migration (cephalad or caudal)
  • No Angiographic Demonstration of Thrombus
  • No Strut Fractures

CHUM

Oliva, Vincent et al. “Recovery G2 Inferior Vena Cava Filter: Technical Success and Safety of Retrieval.” Journal of Vascular and Interventional Radiology; 2008;19:884-889

Purpose: To assess the safety and technical success of the retrieval of the Recovery® G2 filter when implanted for temporary protection against pulmonary embolism. Results of a Prospective, single-center, consecutive single arm clinical trial.

  • Prospective, single-center, non-randomized
  • 120 Patients
  • 53.4 Days Mean Indwell Time
  • 51 Filter Retrieval Attempts
  • 100% Retrieval Success Rate
FDA Communication Regrading IVC Filters, Issued August 9, 2010
Click Here - www.fda.gov
Societal Information


For additional vena cava filter clinical information please refer to the following societal guidelines:

  • "Practice Guideline for the Performance of Percutaneous Inferior Vena Cava Filter Placement for the Prevention of Pulmonary Embolism" [ACR Practice Guideline 2007; 38:673-684]
  • "American College of Chest Physicians: Opinions regarding the diagnosis and management of venous thromboembolic disease. ACCP Consensus Committee on Pulmonary Embolism. American College of Chest Physicians" [ Chest 1998 Feb; 113(2): 499-504]
  • "Practice Management Guidelines for the Prevention of Venous Thromboembolism in Trauma Patients: The EAST Practice Management Guidelines Work Group" [J Trauma 2002; 53:142-614]
  • "Quality Improvement Guidelines for Percutaneous Inferior Vena Cava Filter Placement for the Prevention of Pulmonary Embolism" [JVIR 2003; 14:S271-S275]



Bard Resources